Success Stories: With USCIS Expedite NIW Service's Assistance, a South Korean Research Scientist Secures a National Interest Waiver in Only 5 Days
Client’s Testimonial:
“Wow, thank you so much for this fantastic news!! I am so grateful to hear that my I-140 NIW has been approved. I am extremely grateful for the outstanding service provided by the Attorney and the entire Chen Immigration team. My I-140 NIW was approved the very next day after USCIS received my case package, a testament to the exceptional expertise and efficiency of the firm. Initially, I had some reservations about the messaging-based communication method used by the firm. However, my concerns were quickly alleviated as I found their system not only effective but superior to traditional email communication. The responses were timely, and I always received professional and comprehensive answers to all my queries. The meticulous attention to detail and the tailored guidance provided throughout the process were invaluable. The team's proficiency and dedication were evident in every interaction, making what could have been a daunting process, smooth and straightforward. I cannot recommend Chen Immigration highly enough and will suggest their services to my colleagues without hesitation. If you are looking for a law firm that combines professionalism with efficiency and excellent client support, look no further than Chen Immigration. Thank you to the entire team, for your exceptional support and for playing a crucial role in the success of my application.”
On January 30th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Scientist
Country of Origin: South Korea
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: January 30th, 2024
Processing Time: 5 days (Premium Processing Requested)
Case Summary:
A research scientist in the biological sciences hired North America Immigration Law Group to assist her in submitting a National Interest Waiver (NIW) petition. Before deciding to move forward with her case, we thoroughly assessed her impressive credentials. We were certain that we could guide her to the national interest waiver triumph following the evaluation. Our team is proud to have been the first to customize I-140 petitions in a personalized manner, and this highly customized approach accounts for our acceptance record. Our job was to prove to the USCIS that our client’s efforts are relevant to advanced treatment interventions for neurological diseases and reducing side effects for patients.
Her NIW petition package contained the following facts, which were highlighted:
- Her research elucidates the role of innate immune signaling and cell-type-specific and disease-state-specific pathway regulation in neurodegenerative diseases, thus enabling the development of next-generation diagnostics and therapeutics.
- Her work advancing her proposed endeavor is of great importance because it significantly advances the detection and treatment of neurodegenerative diseases.
- In addition to these achievements, our client has published a number of influential papers in leading journals in the field. Her publication record, i.e. the 12 peer-reviewed journal articles that have appeared in no fewer than 7 highly ranked peer-reviewed journals, therefore affirms the fact that the quality of her findings has set her apart from her peers.
- We also showed that she has not only successfully completed and published the results of her research in the field, but her findings have also gone on to influence her peers. That is, her publications have been cited a total of 3,242 times, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical science.
- Furthermore, 18 eminent organizations that only fund projects aimed at furthering the national interest have in fact funded our client's research due to its evident national importance.